With a market projected to reach US$ 2,301.6 billion by 2032, the pharmaceutical manufacturing industry is not just growing—it’s evolving. The convergence of digital innovation, changing disease ...

Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a specialty pharmaceutical and MedTech company focused on converting ...

Camilla Griffiths named President of 21GRAMS Europe; Mike Nelson relocated to London in new International Client Development ...

A new report has warned that US tariffs could disrupt Ireland's €72bn pharmaceutical exports. The study carried out by global consultancy group Sia states that shifting US trade policies could also ...

Formation Bio, an AI-driven pharmaceutical company revolutionizing drug development, today announced that Mikael Dolsten, MD, PhD, former Chief Scientific Officer and President, Pfizer Research & ...

USA Rare Earth (USARE) went public on Friday, marking its debut on the Nasdaq under the ticker ‘USAR’ as chief executive Joshua Ballard and chairman Mike Blitzer rang the opening bell.

Sangamo Therapeutics, Inc.'s $18M Eli Lilly deal boosts CNS genomic medicines. Fabry gene therapy data in 2025 is key for ...

Negotiating and signing a Letter of Intent (LOI) is a key inflection point in the process of selling your business. Buyers and sellers both want the LOI to ensure a base level of understanding on ...

LONDON — Real Chemistry, a global leader in healthcare marketing and communications, today announced two strategic leadership moves to strengthen its presence in Europe. Camilla Griffiths has been ...

The Vanguard S&P 500 ETF offers investors exceptional exposure to the coming artificial intelligence (AI) revolution. Nearly ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. In the not-so-distant past, advanced artificial intelligence (AI) was a luxury reserved ...